Suppr超能文献

联合筋膜鞘悬吊术与提上睑肌缩短术治疗重度上睑下垂的临床疗效

Clinical Effect of Combined Fascia Sheath Suspension With Shortening Levator Muscle on Severe Blepharoptosis.

作者信息

Wei Ranran, Ding Kun, Zhang Shan, Cao Zhe, Liang Xiaoqin

机构信息

Shandong Second Medical University, Weifang city, Shandong Province, China.

出版信息

J Craniofac Surg. 2024 Jul 29;35(8):e718-22. doi: 10.1097/SCS.0000000000010486.

Abstract

OBJECTIVE

To study the clinical effect of conjoint fascial sheath (CFS) suspension and levator palpebrae superioris muscle shortening in the treatment of severe blepharoptosis.

METHODS

Forty-five patients with severe blepharoptosis (75 eyes) from May 2020 to February 2022 in the authors' hospital were divided into 2 groups: group A (n = 33, 43 eyes) and group B (n = 24, 32 eyes). Group A was operated on by CFS + levator muscle shortening, and group B was operated on by frontal muscle flap suspension + levator muscle shortening. Both groups were followed up for 12 months (until February 2023). The clinical effect was counted in 6 months after operation, the early complications were counted in 1 month after operation, and the late complications were counted in 1 month to 12 months after operation. Margin to corneal reflex distance 1 (MRD1) and palpebral fissure height (PFH) were recorded before, 1 week, 3 months, and 12 months postoperatively, and the amount of eyelid retrogression was counted again.

RESULTS

The good correction rate was 90.70% in group A, higher than in group B (71.88%), and the difference was statistically significant (P< 0.05); the early postoperative complication rate was 9.30%, lower than in group B (24.38%), and the difference was statistically significant (P< 0.05); the late postoperative complication rate was 2.33%, lower than group B (18.75%), and the difference was statistically significant (P< 0.05). The MRD1 and PFH of group A were higher than those of group B (P< 0.05) at 3 months postoperatively and 12 months postoperatively; the MRD1 and PFH of group A were lower than those of group B (P< 0.05) at 3 months postoperatively and 12 months postoperatively. Repeated measurement analysis of variance showed that there were significant differences in the main effects of MRD1, PFH, eyelid retrogression, and time in group A and group B (P< 0.05), and there was interaction between intervention and time (P< 0.05).

CONCLUSION

Conjoint fascial sheath suspension combined with levator palpebrae superioris muscle shortening can effectively improve MRD1 and PFH, and the amount of upper eyelid retraction is controllable 1 year after operation.

摘要

目的

探讨联合筋膜鞘(CFS)悬吊术与提上睑肌缩短术治疗重度上睑下垂的临床效果。

方法

选取2020年5月至2022年2月在作者所在医院就诊的45例重度上睑下垂患者(75只眼),分为A组(n = 33,43只眼)和B组(n = 24,32只眼)。A组采用CFS + 提上睑肌缩短术,B组采用额肌瓣悬吊术 + 提上睑肌缩短术。两组均随访12个月(至2023年2月)。术后6个月统计临床效果,术后1个月统计早期并发症,术后1个月至12个月统计晚期并发症。记录术前、术后1周、3个月和12个月时的角膜反射缘与上睑缘距离1(MRD1)及睑裂高度(PFH),再次统计上睑退缩量。

结果

A组良好矫正率为90.70%,高于B组(71.88%),差异有统计学意义(P < 0.05);术后早期并发症发生率为9.30%,低于B组(24.38%),差异有统计学意义(P < 0.05);术后晚期并发症发生率为2.33%,低于B组(18.75%),差异有统计学意义(P < 0.05)。术后3个月和12个月时,A组的MRD1和PFH均高于B组(P < 0.05);术后3个月和12个月时,A组的MRD1和PFH均低于B组(P < 0.05)。重复测量方差分析显示,A组和B组在MRD1、PFH、上睑退缩及时间的主效应方面存在显著差异(P < 0.05),干预与时间之间存在交互作用(P < 0.05)。

结论

联合筋膜鞘悬吊联合提上睑肌缩短术可有效改善MRD1和PFH,术后1年上睑退缩量可控。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验